Terms: = Liver cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Clinical Outcome
7 results:
1. ScRNA-seq revealed targeting regulator of G protein signaling 1 to mediate regulatory T cells in Hepatocellular carcinoma.
Zou L; Liu K; Shi Y; Li G; Li H; Zhao C
Cancer Biomark; 2023; 36(4):299-311. PubMed ID: 36938729
[TBL] [Abstract] [Full Text] [Related]
2. Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-cxcr4 axis.
Martinez-Ordoñez A; Seoane S; Cabezas P; Eiro N; Sendon-Lago J; Macia M; Garcia-Caballero T; Gonzalez LO; Sanchez L; Vizoso F; Perez-Fernandez R
Oncogene; 2018 Mar; 37(11):1430-1444. PubMed ID: 29321662
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic significance of USP33 in advanced colorectal cancer patients: new insights into β-arrestin-dependent ERK signaling.
Liu H; Zhang Q; Li K; Gong Z; Liu Z; Xu Y; Swaney MH; Xiao K; Chen Y
Oncotarget; 2016 Dec; 7(49):81223-81240. PubMed ID: 27835898
[TBL] [Abstract] [Full Text] [Related]
4. Honokiol suppresses pancreatic tumor growth, metastasis and desmoplasia by interfering with tumor-stromal cross-talk.
Averett C; Bhardwaj A; Arora S; Srivastava SK; Khan MA; Ahmad A; Singh S; Carter JE; Khushman M; Singh AP
Carcinogenesis; 2016 Nov; 37(11):1052-1061. PubMed ID: 27609457
[TBL] [Abstract] [Full Text] [Related]
5. CXCL12-cxcr4 axis promotes the natural selection of breast cancer cell metastasis.
Sun Y; Mao X; Fan C; Liu C; Guo A; Guan S; Jin Q; Li B; Yao F; Jin F
Tumour Biol; 2014 Aug; 35(8):7765-73. PubMed ID: 24810923
[TBL] [Abstract] [Full Text] [Related]
6. cxcr4/CXCL12 expression profile is associated with tumor microenvironment and clinical outcome of liver metastases of colorectal cancer.
Sakai N; Yoshidome H; Shida T; Kimura F; Shimizu H; Ohtsuka M; Takeuchi D; Sakakibara M; Miyazaki M
Clin Exp Metastasis; 2012 Feb; 29(2):101-10. PubMed ID: 22075627
[TBL] [Abstract] [Full Text] [Related]
7. Chemokine receptor cxcr4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival.
Xiang ZL; Zeng ZC; Tang ZY; Fan J; Zhuang PY; Liang Y; Tan YS; He J
BMC Cancer; 2009 Jun; 9():176. PubMed ID: 19508713
[TBL] [Abstract] [Full Text] [Related]